Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Monoclonal Antibody to Target CD20 for Non-Hodgkin Lymphoma by Shenzhen Salubris Pharmaceuticals for Non-Hodgkin Lymphoma: Likelihood of Approval
Monoclonal Antibody to Target CD20 for Non-Hodgkin Lymphoma is under clinical development by Shenzhen Salubris Pharmaceuticals and currently in Phase...